Diabetogenesis in Rheumatoid Arthritis: Do Inflammation and Glucocorticoid-induced Incretin Overproduction Cause β-Cell Overcompensation and Consequent Premature Decompensation?

REFERENCES

1. 1.↵
   1. Dessein PH,
   2. Solomon A,
   3. Hollan I

   . Metabolic abnormalities in patients with inflammatory rheumatic diseases. Best Pract Res Clin Rheumatol 2016;30:901–15.

   OpenUrl
2. 2.↵
   1. Bayer JF,
   2. Gourraud PA,
   3. Cantagrel A,
   4. Davignon JL,
   5. Constantin A

   . Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis. Joint Bone Spine 2011;78:179–83.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Baghdadi LR,
   2. Woodman RJ,
   3. Shanahan EM,
   4. Mangoni A

   . The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis. PLoS One 2015;10:e0117952.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Ruscitti P,
   2. Ursini F,
   3. Cipriani P,
   4. Liakouli V,
   5. Carubbi F,
   6. Berardicurti O,
   7. et al.

   Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year single-centre, longitudinal study. PLoS One 2017;12:e0181203.

   OpenUrl
5. 5.↵
   1. Lewis GF,
   2. Carpentier A,
   3. Adeli K,
   4. Giacca A

   . Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocrine Reviews 2002;23:201–29.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Dessein PH,
   2. Joffe BI,
   3. Stanwix AE

   . Inflammation, insulin resistance, and aberrant lipid metabolism as cardiovascular risk factors in rheumatoid arthritis. J Rheumatol 2003;30:1403–5.

   OpenUrlFREE Full Text
7. 7.↵
   1. Kahn SE,
   2. Prigeon RL,
   3. Schwarts RS,
   4. Fujimoto WY,
   5. Knopp RH,
   6. Brunzell JD,
   7. et al.

   Obesity, body fat distribution, insulin sensitivity and islet beta-cell function as explanations for metabolic diversity. J Nutr 2001;131:354S–360S.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Meier JJ,
   2. Veldhuis JD,
   3. Butler PC

   . Pulsatile insulin secretion dictates systemic insulin delivery by regulating hepatic insulin extraction in humans. Diabetes 2005;54:1649–58.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Cersosimo E,
   2. Solis-Herrera C,
   3. Trautman ME,
   4. Malloy J,
   5. Triplitt CL

   . Assessment of pancreatic β-cell function: review of methods and clinical applications. Curr Diabetes Rev 2014;10:2–42.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Nicolau J,
    2. Lequerre T,
    3. Bacquet H,
    4. Vittecoq O

    . Rheumatoid arthritis, insulin resistance, and diabetes. Joint Spine Bone 2017;84:411–6.

    OpenUrl
11. 11.↵
    1. Dessein PH,
    2. Joffe BI

    . Insulin resistance and impaired beta cell function in rheumatoid arthritis. Arthritis Rheum 2006;54:2765–75.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Dessein PH,
    2. Joffe BI,
    3. Stanwix AE

    . Subclinical hypothyroidism is associated with insulin resistance in rheumatoid arthritis. Thyroid 2004;14:443–6.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Ferraz-Amaro I,
    2. Garcia-Dopico JA,
    3. Medina-Vega L,
    4. Gonzalez-Gay MA,
    5. Diaz-Gonzalez F

    . Impaired beta cell function is present in nondiabetic rheumatoid arthritis patients. Arthritis Res Ther 2013;15:R17.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Stagakis I,
    2. Bersias G,
    3. Karvounaris S,
    4. Kavousanaki M,
    5. Virla D,
    6. Raptopoulou A,
    7. et al.

    Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance. Arthritis Res Ther 2012;14:R141.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Wasko MC,
    2. McClure CK,
    3. Kelsey SF,
    4. Huber K,
    5. Orchard T,
    6. Toledo FG

    . Antidiabetogenic effects of hydroxychloroquine on insulin sensitivity and beta cell function: a randomised trial. Diabetologia 2015;58:2336–43.

    OpenUrl
16. 16.↵
    1. Tejera-Segura B,
    2. Lopez-Mejias R,
    3. de Vera-Gonzalez AM,
    4. Jiménez-Sosa A,
    5. Olmos JM,
    6. Hernández JL,
    7. et al.

    Relationship between insulin sensitivity and β-cell secretion in nondiabetic subjects with rheumatoid arthritis. J Rheumatol 2019;46:229–36.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Tejera-Segura B,
    2. López-Mejías R,
    3. Dominguez-Luis MJ,
    4. de Vera-González AM,
    5. González-Delgado A,
    6. Ubilla B,
    7. et al.

    Incretins in patients with rheumatoid arthritis. Arthritis Res Ther 2017;19:229.

    OpenUrl
18. 18.↵
    1. Kim W,
    2. Egan JM

    . The role of incretins in glucose homeostasis and diabetes treatment. Pharmacol Rev 2008;60:470–512.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Gower BA,
    2. Granger WM,
    3. Franklin F,
    4. Shechuk RM,
    5. Goran MI

    . Contribution of insulin secretion and clearance to glucose-induced insulin concentrations in African-American and Caucasian children. J Clin Endocrinol Metab 2002;87:2218–24.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Hoes JN,
    2. van der Goes MC,
    3. van Raalte DH,
    4. van der Zijl NJ,
    5. den Uyl D,
    6. Lems WF,
    7. et al.

    Glucose tolerance, insulin sensitivity and β-cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoids. Ann Rheum Dis 2011;70:1887–94.

    OpenUrlAbstract/FREE Full Text